{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:37:31Z","timestamp":1786628251775,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02435-8","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:35:22Z","timestamp":1779809722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of myelosuppression in cervical cancer after concurrent chemoradiotherapy by CT radiomics-based model"],"prefix":"10.1186","volume":"26","author":[{"given":"Chen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"3","key":"2435_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinicians. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clinicians"},{"issue":"5","key":"2435_CR2","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/01.AOG.0000215986.48590.79","volume":"107","author":"DH Moore","year":"2006","unstructured":"Moore DH. Cervical cancer. Obstet Gynecol. 2006;107(5):1152\u201361. https:\/\/doi.org\/10.1097\/01.AOG.0000215986.48590.79.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2435_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3109\/01443615.2015.1134458","volume":"36","author":"J Yang","year":"2016","unstructured":"Yang J, Yin J, Yan G, Huang D, Wang J. Postoperative chemoradiotherapy versus radiotherapy alone for cervical cancer: a systematic review and meta-analysis. J Obstet Gynaecol. 2016;36(5):641\u201348. https:\/\/doi.org\/10.3109\/01443615.2015.1134458.","journal-title":"J Obstet Gynaecol"},{"key":"2435_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.radonc.2021.09.009","volume":"164","author":"A Corbeau","year":"2021","unstructured":"Corbeau A, Kuipers SC, de Boer SM, Horeweg N, Hoogeman MS, Godart J, et al. Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review. Radiother Oncol. 2021;164:128\u201337. https:\/\/doi.org\/10.1016\/j.radonc.2021.09.009.","journal-title":"Radiother Oncol"},{"issue":"10","key":"2435_CR5","first-page":"3351","volume":"49","author":"SP Rowe","year":"2022","unstructured":"Rowe SP, Nair S, Bomanji JB, et al. CT radiomics predicts radium-223-induced myelosuppression in metastatic castration-resistant prostate cancer. Eur J Nucl Med Mol Imag. 2022;49(10):3351\u201361.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"2435_CR6","doi-asserted-by":"publisher","first-page":"1287121","DOI":"10.3389\/fonc.2023.1287121","volume":"13","author":"C Xu","year":"2023","unstructured":"Xu C, Liu W, Zhao Q, Zhang L, Yin M, Zhou J, et al. CT-based radiomics nomogram for overall survival prediction in patients with cervical cancer treated with concurrent chemoradiotherapy. Front Oncol. 2023;13:1287121. https:\/\/doi.org\/10.3389\/fonc.2023.1287121.","journal-title":"Front Oncol"},{"issue":"3","key":"2435_CR7","first-page":"385","volume":"44","author":"X Zhou","year":"2017","unstructured":"Zhou X, Li Y, Lu F, Yin Y. Applying logistic LASSO regression for the diagnosis of atypical Crohn\u2019s disease. Fudan Univ J Med Sci. 2017;44(3):385\u201390.","journal-title":"Fudan Univ J Med Sci"},{"issue":"12","key":"2435_CR8","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.3390\/diagnostics12123130","volume":"12","author":"Y Guo","year":"2022","unstructured":"Guo Y, Wu J, Wang Y, Jin Y. Development and validation of an ultrasound-based radiomics nomogram for identifying HER2 status in patients with breast carcinoma. Diagn (Basel). 2022;12(12):3075. https:\/\/doi.org\/10.3390\/diagnostics12123130.","journal-title":"Diagn (Basel)"},{"issue":"10","key":"2435_CR9","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.7150\/ijms.95900","volume":"21","author":"B Deng","year":"2024","unstructured":"Deng B, Kong W, Han C, Zhou C, Li J, Song D, et al. Study of long-term effects of pelvic radiotherapy on the function of bone marrow in recurrent cervical cancer patients. Int J Med Sci. 2024;21(10):2000\u201310. https:\/\/doi.org\/10.7150\/ijms.95900.","journal-title":"Int J Med Sci"},{"issue":"5","key":"2435_CR10","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","volume":"66","author":"LK Mell","year":"2006","unstructured":"Mell LK, Kochanski JD, Roeske JC, Haslam JJ, Mehta N, Yamada SD, et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Multiling Radiat Oncol*Biol*Phys. 2006, Dec, 1;66(5):1356\u201365. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.03.018.","journal-title":"Int J Multiling Radiat Oncol*Biol*Phys"},{"issue":"4","key":"2435_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.ijrobp.2009.12.025","volume":"79","author":"K Albuquerque","year":"2011","unstructured":"Albuquerque K, Giangreco D, Morrison C, Siddiqui M, Sinacore J, Potkul R, et al. Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow\u2013sparing pelvic IMRT. Int J Multiling Radiat Oncol*Biol*Phys. 2011, Mar, 15;79(4):1043\u201347. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.12.025.","journal-title":"Int J Multiling Radiat Oncol*Biol*Phys"},{"issue":"1","key":"2435_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13014-022-02018-1","volume":"17","author":"X Xiang","year":"2022","unstructured":"Xiang X, Ding Z, Zeng Q, Feng L, Qiu C, Chen D, et al. Dosimetric parameters and absolute monocyte count can predict the prognosis of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemotherapy and volumetric-modulated arc therapy. Radiat Oncol. 2022, Mar, 5;17(1):48. https:\/\/doi.org\/10.1186\/s13014-022-02018-1.","journal-title":"Radiat Oncol"},{"issue":"4","key":"2435_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4103\/jcrt.jcrt_132_25","volume":"21","author":"Y Lei","year":"2025","unstructured":"Lei Y, Bai H, Yu J, Zhang Z, Wang L, Li B, et al. Research progress of dosiomics in precision radiotherapy. J Cancer Res Ther. 2025, Sep, 1;21(4):787\u201395. https:\/\/doi.org\/10.4103\/jcrt.jcrt_132_25.","journal-title":"J Cancer Res Ther"},{"key":"2435_CR14","doi-asserted-by":"publisher","first-page":"1365897","DOI":"10.3389\/fonc.2024.1365897","volume":"14","author":"H Yue","year":"2024","unstructured":"Yue H, Li X, You J, Feng P, Du Y, Wang R, et al. Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter? Front Oncol. 2024;14:1365897. https:\/\/doi.org\/10.3389\/fonc.2024.1365897.","journal-title":"Front Oncol"},{"key":"2435_CR15","doi-asserted-by":"publisher","first-page":"1516855","DOI":"10.3389\/fonc.2025.1516855","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, Guo L, Wang Y, Xu Q, Zhang J, Meng X. Radiation hematologic toxicity prediction in rectal cancer: a comparative radiomics-based study on CT image and dose map. Front Oncol. 2025;15:1516855. https:\/\/doi.org\/10.3389\/fonc.2025.1516855.","journal-title":"Front Oncol"},{"issue":"2","key":"2435_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/1471-0528.17285","volume":"130","author":"K Ren","year":"2023","unstructured":"Ren K, Shen L, Qiu J, Sun K, Chen T, Xuan L, et al. Treatment planning computed tomography radiomics for predicting treatment outcomes and haematological toxicities in locally advanced cervical cancer treated with radiotherapy: a retrospective cohort study. BJOG: Int J Obstet Gynaecol. 2023;130(2):222\u201330. https:\/\/doi.org\/10.1111\/1471-0528.17285.","journal-title":"BJOG: Int J Obstet Gynaecol"},{"issue":"12","key":"2435_CR17","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.6004\/jnccn.2023.0062","volume":"21","author":"NR Abu-Rustum","year":"2023","unstructured":"Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, et al. NCCN Guidelines\u00ae insights: cervical cancer, version 1. 2024. J Natl Compr Cancer Network: JNCCN. 2023;21(12):1224\u201333. https:\/\/doi.org\/10.6004\/jnccn.2023.0062.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"1","key":"2435_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/AOG.0000000000003311","volume":"134","author":"JD Wright","year":"2019","unstructured":"Wright JD, Matsuo K, Huang Y, Tergas AI, Hou JY, Khoury-Collado F, et al. Prognostic performance of the 2018 international Federation of gynecology and obstetrics cervical cancer staging Guidelines. Prognostic Perform The 2018 Int Fed Gynecology Obstet Cerv Cancer Staging Guidelines. Obstet Gynecology. 2019;134(1):49\u201357. https:\/\/doi.org\/10.1097\/AOG.0000000000003311.","journal-title":"Prognostic Perform The 2018 Int Fed Gynecology Obstet Cerv Cancer Staging Guidelines. Obstet Gynecology"},{"key":"2435_CR19","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3389\/fonc.2020.01179","volume":"10","author":"LK Vitzthum","year":"2020","unstructured":"Vitzthum LK, Heide ES, Park H, Williamson CW, Sheridan P, Huynh-Le MP, et al. Comparison of hematologic toxicity and bone marrow Compensatory response in Head and Neck vs. Cervical cancer patients undergoing chemoradiotherapy. Front Oncol. 2020, Jul, 21;10:1179. https:\/\/doi.org\/10.3389\/fonc.2020.01179.","journal-title":"Front Oncol"},{"issue":"9","key":"2435_CR20","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1089\/ars.2013.5635","volume":"20","author":"L Shao","year":"2014","unstructured":"Shao L, Luo Y, Zhou D. Hematopoietic stem cell injury induced by ionizing radiation. Antioxid Redox Signal. 2014, Mar, 20;20(9):1447\u201362. https:\/\/doi.org\/10.1089\/ars.2013.5635. 2014 Feb 10.","journal-title":"Antioxid Redox Signal"},{"key":"2435_CR21","doi-asserted-by":"publisher","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics System to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104\u201307. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0339.","DOI":"10.1158\/0008-5472.CAN-17-0339"},{"issue":"1","key":"2435_CR22","doi-asserted-by":"publisher","first-page":"11340","DOI":"10.1038\/s41598-022-15609-5","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Lu F, Yin Y. Applying logistic LASSO regression for the diagnosis of atypical Crohn\u2019s disease. Sci Rep. 2022;12(1):11340. https:\/\/doi.org\/10.1038\/s41598-022-15609-5.","journal-title":"Sci Rep"},{"issue":"7","key":"2435_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.21037\/atm.2019.03.29","volume":"7","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhao Y, Canes A, Steinberg D, Lyashevska O. Predictive analytics with gradient boosting in clinical medicine. Annals of translational medicine 2019. Ann. Transl. Med. 2019;7(7):152. https:\/\/doi.org\/10.21037\/atm.2019.03.29.","journal-title":"Ann. Transl. Med"},{"key":"2435_CR24","doi-asserted-by":"publisher","first-page":"1111976","DOI":"10.3389\/fgene.2023.1111976","volume":"14","author":"P Yan","year":"2023","unstructured":"Yan P, Ke B, Song J, Fang X. Identification of immune-related molecular clusters and diagnostic markers in chronic kidney disease based on cluster analysis. Front Genet. 2023;14:1111976. https:\/\/doi.org\/10.3389\/fgene.2023.1111976.","journal-title":"Front Genet"},{"issue":"Code Snippet 2","key":"2435_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.18637\/jss.v079.c02","volume":"79","author":"MC Sachs","year":"2017","unstructured":"Sachs MC. plotROC: a tool for plotting ROC curves. J Stat Soft. 2017;79(Code Snippet 2):79. https:\/\/doi.org\/10.18637\/jss.v079.c02.","journal-title":"J Stat Soft"},{"key":"2435_CR26","doi-asserted-by":"publisher","first-page":"200238","DOI":"10.1016\/j.tvr.2022.200238","volume":"13","author":"CA Burmeister","year":"2022","unstructured":"Burmeister CA, Khan SF, Sch\u00e4fer G, Mbatani N, Adams T, Moodley J, et al. Cervical cancer therapies: current challenges and future perspectives. Tumour Virus Res. 2022;13:200238. https:\/\/doi.org\/10.1016\/j.tvr.2022.200238.","journal-title":"Tumour Virus Res"},{"issue":"3","key":"2435_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/ijgc-2021-003001","volume":"32","author":"JS Mayadev","year":"2022","unstructured":"Mayadev JS, Ke G, Mahantshetty U, Pereira MD, Tarnawski R, Toita T. Global challenges of radiotherapy for the treatment of locally advanced cervical cancer. Int J Gynecological Cancer: Off J The In-Ternational Gynecological Cancer Soc. 2022;32(3):436\u201345.22. https:\/\/doi.org\/10.1136\/ijgc-2021-003001.","journal-title":"Int J Gynecological Cancer: Off J The In-Ternational Gynecological Cancer Soc"},{"key":"2435_CR28","doi-asserted-by":"publisher","first-page":"993443","DOI":"10.3389\/fpubh.2022.993443","volume":"10","author":"X Meng","year":"2022","unstructured":"Meng X, Wang N, Yu M, Kong D, Zhang Z, Chang X, et al. Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy. Front Public Health. 2022;10:993443. https:\/\/doi.org\/10.3389\/fpubh.2022.993443.","journal-title":"Front Public Health"},{"issue":"3","key":"2435_CR29","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00404-020-05908-5","volume":"303","author":"D Liu","year":"2021","unstructured":"Liu D, Zhang X, Zheng T, Shi Q, Cui Y, Wang Y, et al. Optimisation and evaluation of the random forest model in the efficacy prediction of chemoradiotherapy for advanced cervical cancer based on radiomics signature from high-resolution T2 weighted images. Arch Gynecol Obstet. 2021;303(3):811\u201320. https:\/\/doi.org\/10.1007\/s00404-020-05908-5.","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"2435_CR30","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.3390\/diagnostics12123130","volume":"12","author":"Y Guo","year":"2022","unstructured":"Guo Y, Wu J, Wang Y, Jin Y. Development and validation of an ultrasound-based radiomics nomogram for identifying HER2 status in patients with breast carcinoma. Diagn (Basel, Switz). 2022;12(12):3130. https:\/\/doi.org\/10.3390\/diagnostics12123130.","journal-title":"Diagn (Basel, Switz)"},{"issue":"10","key":"2435_CR31","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2174\/1573405618666220930150625","volume":"19","author":"SN S","year":"2023","unstructured":"S SN. Prediction of breast cancer through random forest. CMIR. 2023;19(10):1144\u201355. https:\/\/doi.org\/10.2174\/1573405618666220930150625.","journal-title":"CMIR"},{"issue":"1","key":"2435_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s40001-023-01361-7","volume":"28","author":"Y Jin","year":"2023","unstructured":"Jin Y, Lan A, Dai Y, Jiang L, Liu S. Development and testing of a random forest-based machine learning model for predicting events among breast cancer patients with a poor response to neoadjuvant chemotherapy. Eur J Med Res. 2023;28(1):394. https:\/\/doi.org\/10.1186\/s40001-023-01361-7.","journal-title":"Eur J Med Res"},{"issue":"6","key":"2435_CR33","first-page":"4155","volume":"15","author":"Y Dong","year":"2023","unstructured":"Dong Y, Hu C, Liu J, Lv H. Construction of an auxiliary scoring model for myelosuppression in patients with lung cancer chemotherapy based on random forest algorithm. Am J Transl Res. 2023;15(6):4155\u201363.","journal-title":"Am J Transl Res"},{"key":"2435_CR34","doi-asserted-by":"publisher","first-page":"107327482211269","DOI":"10.1177\/10732748221126929","volume":"29","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, Zhang Q, Han Y, Wu T, Zhang Y. Predictive model of chemotherapy-induced myelosuppression for patients with esophageal cancer. Cancer Control: J Moffitt Cancer Cent: J The Moffitt Cancer Cent. 2022;29:10732748221126929. https:\/\/doi.org\/10.1177\/10732748221126929.","journal-title":"Cancer Control: J Moffitt Cancer Cent: J The Moffitt Cancer Cent"},{"issue":"4","key":"2435_CR35","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1007\/s00330-020-07320-8","volume":"31","author":"CP Reinert","year":"2021","unstructured":"Reinert CP, Krieg E, Esser M, Nikolaou K, B\u00f6sm\u00fcller H, Horger M. Role of computed tomography texture analysis using dual-energy-based bone marrow imaging for multiple myeloma characterization: comparison with histology and established serologic parameters. Eur Radiol. 2021, Apr;31(4):2357\u201367. https:\/\/doi.org\/10.1007\/s00330-020-07320-8.","journal-title":"Eur Radiol"},{"issue":"2","key":"2435_CR36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/1471-0528.17285","volume":"130","author":"K Ren","year":"2023","unstructured":"Ren K, Shen L, Qiu J, Sun K, Chen T, Xuan L, et al. Treatment planning computed tomography radiomics for predicting treatment outcomes and haematological toxicities in locally advanced cervical cancer treated with radiotherapy: a retrospective cohort study. BJOG. 2023, Jan;130(2):222\u201330. https:\/\/doi.org\/10.1111\/1471-0528.17285.","journal-title":"BJOG"},{"key":"2435_CR37","doi-asserted-by":"publisher","unstructured":"Avanzo M, Wei L, Stancanello J, Valli\u00e8res M, Rao A, Morin O, et al. Machine and deep learning methods for radiomics. Med Phys. 2020;47(5):e185\u2013202. https:\/\/doi.org\/10.1002\/mp.13678.","DOI":"10.1002\/mp.13678"},{"issue":"2","key":"2435_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40846-024-00863-x","volume":"44","author":"X Li","year":"2024","unstructured":"Li X, Zhang L, Yang J, Teng F. Role of Artificial Intelligence in medical image analysis: a review of Current trends and future directions. J Med Biol Eng. 2024;44(2):231\u201343. https:\/\/doi.org\/10.1007\/s40846-024-00863-x.","journal-title":"J Med Biol Eng"},{"key":"2435_CR39","doi-asserted-by":"publisher","first-page":"103460","DOI":"10.1016\/j.ebiom.2021.103460","volume":"69","author":"Y Yu","year":"2021","unstructured":"Yu Y, He Z, Ouyang J, Tan Y, Chen Y, Gu Y, et al. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: a machine learning, multicenter study. EBioMedicine. 2021;69:103460. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103460.","journal-title":"EBioMedicine"},{"issue":"18","key":"2435_CR40","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","volume":"34","author":"YQ Huang","year":"2016","unstructured":"Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, et al. Development and validation of a radiomics nomogram for Preoperative prediction of lymph node metastasis in colorectal cancer. JCO. 2016;34(18):2157\u201364. https:\/\/doi.org\/10.1200\/JCO.2015.65.9128.","journal-title":"JCO"},{"issue":"7","key":"2435_CR41","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.annonc.2020.04.003","volume":"31","author":"D Dong","year":"2020","unstructured":"Dong D, Fang MJ, Tang L, Shan XH, Gao JB, Giganti F, et al. Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study. Ann Oncol. 2020;31(7):912\u201320. https:\/\/doi.org\/10.1016\/j.annonc.2020.04.003.","journal-title":"Ann Oncol"},{"issue":"1","key":"2435_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1148\/radiol.220329","volume":"306","author":"Y Bian","year":"2023","unstructured":"Bian Y, Zheng Z, Fang X, Jiang H, Zhu M, Yu J, et al. Artificial Intelligence to predict lymph node metastasis at CT in pancreatic Ductal Adenocarcinoma. Artif. Intell To Predict Lymph Node Metastasis CT Pancreat Ductal Adenocarcinoma. Radiol. 2023;306(1):160\u201369. https:\/\/doi.org\/10.1148\/radiol.220329.","journal-title":"Artif. Intell To Predict Lymph Node Metastasis CT Pancreat Ductal Adenocarcinoma. Radiol"},{"issue":"8","key":"2435_CR43","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1007\/s00259-023-06180-w","volume":"50","author":"F Lucia","year":"2023","unstructured":"Lucia F, Bourbonne V, Pleyers C, Dupr\u00e9 PF, Miranda O, Visvikis D, et al. Multicentric development and evaluation of 18F-FDG PET\/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer. Eur J Nucl Med Mol Imag. 2023;50(8):2514\u201328. https:\/\/doi.org\/10.1007\/s00259-023-06180-w.","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"2435_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13244-022-01346-w","volume":"14","author":"Q Huang","year":"2023","unstructured":"Huang Q, Deng B, Wang Y, Shen Y, Hu X, Feng C, et al. Reduced field-of-view DWI\u2011derived clinical\u2013radiomics model for the prediction of stage in cervical cancer. Insights Imag. 2023;14(1):18. https:\/\/doi.org\/10.1186\/s13244-022-01346-w.","journal-title":"Insights Imag"},{"issue":"1","key":"2435_CR45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10278-023-00906-w","volume":"37","author":"H Yan","year":"2024","unstructured":"Yan H, Huang G, Yang Z, Chen Y, Xiang Z. Machine learning-based multiparametric Magnetic resonance imaging radiomics model for Preoperative predicting the deep stromal invasion in patients with early cervical cancer. J Digit Imag Inf Med. 2024;37(1):230\u201346. https:\/\/doi.org\/10.1007\/s10278-023-00906-w.","journal-title":"J Digit Imag Inf Med"},{"key":"2435_CR46","doi-asserted-by":"crossref","unstructured":"Tangjitgamol S, Katanyoo K, Laopaiboon M, Lumbiganon P, Manusirivithaya S, Supawattanabodee B. Adju-vant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. The Cochrane Database Sys-Tematic Rev. 2014;2014(12):Cd010401.","DOI":"10.1002\/14651858.CD010401"},{"issue":"5","key":"2435_CR47","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1080\/01443615.2021.2012437","volume":"42","author":"L Zhong","year":"2022","unstructured":"Zhong L, Li K, Song L, Yin R. The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis. J Obstet Gynaecol. 2022;42(5):830\u201337. https:\/\/doi.org\/10.1080\/01443615.2021.2012437.","journal-title":"J Obstet Gynaecol"},{"issue":"1081","key":"2435_CR48","doi-asserted-by":"publisher","first-page":"20170398","DOI":"10.1259\/bjr.20170398","volume":"91","author":"HC Luo","year":"2018","unstructured":"Luo HC, Lin GS, Liao SG, Wang FM, Cheng HH, Feng J, et al. Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG). The Br J Radiol. 2018;91(1081):20170398. https:\/\/doi.org\/10.1259\/bjr.20170398.","journal-title":"The Br J Radiol"},{"issue":"1","key":"2435_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13014-020-01606-3","volume":"15","author":"J Huang","year":"2020","unstructured":"Huang J, Gu F, Ji T, Zhao J, Li G. Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial. Radiat Oncol. 2020;15(1):180. https:\/\/doi.org\/10.1186\/s13014-020-01606-3.","journal-title":"Radiat Oncol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02435-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02435-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02435-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:03:27Z","timestamp":1786626207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02435-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2435"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02435-8","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the Ethics Committee in Clinical Research (ECCR) of the Second Affiliated Hospital of Zhengzhou University. The IRB number was 4,101,035,716,743\uff0cthe protocol code was KY2024162.It was conducted following the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"398"}}